Pompe Disease Treatment Market Size Share Analysis 2023

1. Pompe Disease Treatment Market (2023-29) 1

2. Market Overview: The global pompe disease treatment market size was valued at USD 1.2 billion in 2022 and is poised to grow at a significant CAGR of 8% during the forecast period 2023-29. The pompe disease treatment market research report also provides opportunities for business owners to exploit through the use of relevant approaches. The study’s prospects assist stakeholders and report purchasers in properly planning their investments and augmenting their profits. The report provides a quantitative analysis of the market segments, trends, estimations, and dynamics of the pompe disease treatment market analysis from 2023 to 2029 to identify the prevailing market opportunities. In addition, the report discusses the implications of COVID-19, including the industry's initial response and strategies for ensuring business continuity in the coming years. View Detailed Report Description 2

3. Market Segments: The pompe disease treatment market has been fragmented based on: 1. By Treatment Type: Enzyme Replacement Therapy, Gene Therapy 2. By Age Group Type: infantile-Onset Pompe Disease, Late-Onset Pompe Disease. 3. By Geography: North America, Asia Pacific, Europe, Middle East, and Africa, Latin America Request Sample Report 3

4. Key Players: Some of the major key players in the pompe disease treatment market are: Actus Therapeutics, Inc. BioMarin Pharmaceutical Audentes Therapeutics Amicus Therapeutics Sanofi Genozyme Greenovation Biotech GmbH Request Sample Report 4

5. Europe Office: Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX Asia-Pacific Office: Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad – 500072 Email: sales@precisionbusinessinsights.com Toll-Free: +1-866-598-1553 5